
Oral solid dose from a GMP manufacturer: immediate-release, modified-release, dispersible and chewable tablets, released against USP, EP, BP or CP monographs.

Oral solid dose from a GMP manufacturer: immediate-release, modified-release, dispersible and chewable tablets, released against USP, EP, BP or CP monographs.
Tablets are the default presentation for oral medicines on the WHO Model List, and the list writes dosage forms precisely: where a medicine is listed as a dispersible tablet for paediatric use, a standard compressed tablet is not an equivalent substitution for that programme.
Yes. Dispersible and chewable tablets are produced as distinct presentations with their own specification, because the WHO Model List treats them as separate lines from standard compressed tablets.
Immediate release, sustained or modified release, enteric-coated, dispersible, chewable and film-coated. The profile is fixed in the written specification before manufacture.
Dissolution method validation and comparative profile data are prepared as part of the dossier and follow the monograph or the method agreed with your authority.
Every line is quoted against a written specification: monograph, strength, pack configuration, release tests and the documents that ship with the batch. Certificates of analysis, stability data and the GMP certificate accompany each consignment; dossier and registration support are provided where the market requires a filing.
Send a requirement · full product catalogue · therapeutic ranges
Reference information only. Published guidance is quoted for professional and regulatory-context purposes and is not medical advice or a prescribing recommendation.